Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology

Zeitschrift fur Gastroenterologie

Volumn 47, Issue 5, 2009, Pages 417-423

  Heringlake, Stefan ^a,b   Schutte A ^b   Flemming, P ^c   Schmiegel, W ^a   Manns, M P ^b   Tillmann, H L ^b,d  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c ALLGEMEINES KRANKENHAUS CELLE   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Autoimmune hepatitis; Cryptogenic liver disease; International Autoimmune Hepatitis Score

Indexed keywords

AMINOTRANSFERASE; AUTOANTIBODY; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; LIVER ENZYME; PREDNISOLONE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC LIVER DISEASE; CRYPTOGENIC LIVER DISEASE; DISEASE DURATION; FEMALE; GERMANY; HEPATITIS VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER DISEASE; LIVER TOXICITY; LIVER TRANSPLANTATION; MACACA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SEROLOGY; UNIVERSITY HOSPITAL; VIRUS ETIOLOGY; VIRUS HEPATITIS; VIRUS TRANSMISSION;

ADULT; ANIMALS; AUTOANTIBODIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FEMALE; GERMANY; HEPATITIS, AUTOIMMUNE; HEPATITIS, CHRONIC; HEPATITIS, TOXIC; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MACACA FASCICULARIS; MACACA MULATTA; MALE; MIDDLE AGED; SAGUINUS;

EID: 66649136969     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109146     Document Type: Article

References (47)

1. Kodali VP, Gordon SC, Silverman AL et al. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 1994; 89: 1836-1839 (Pubitemid 24320552)
2. Saunders JB, Walters JR, Davies AP et al. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 1981; 282: 263-266 (Pubitemid 11188540)
3. Schiodt FV, Atillasoy E, Shakil AO et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5: 29-34 (Pubitemid 29037351)
4. Nunez-Martinez O, De la Cruz G, De Diego A et al. Liver transplantation for fulminant and subfulminant hepatic failure. Transplant Proc 2003; 35: 1855-1856 (Pubitemid 37093739)
5. Belle SH, Beringer KC, Detre KM. An update on liver transplantation in the United States: recipient characteristics and outcome. Clin Transpl 1995: 19-33
6. Charlton MR, Kondo M, Roberts SK et al. Liver transplantation for cryptogenic cirrhosis. Liver Transpl Surg 1997; 3: 359-364 (Pubitemid 27310174)
7. Sanjeevi A, Lyden E, Sunderman B et al. Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients. Transplant Proc 2003; 35: 2977-2980 (Pubitemid 38102106)
8. Raimondo G, Balsano C, Craxi A et al. Occult hepatitis B virus infection. Dig Liver Dis 2000; 32: 822-826
9. Schmidt WN, Wu P, Cederna J et al. Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. J Infect Dis 1997; 176: 27-33 (Pubitemid 27272848)
10. Heringlake S, Tillmann HL, Manns MP. New hepatitis viruses. J Hepatol 1996; 25: 239-247 (Pubitemid 26276640)
11. Czaja AJ. Variant forms of autoimmune hepatitis. Curr Gastroenterol Rep 1999; 1: 63-70
12. Browning JD, Kumar KS, Saboorian MH et al. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol 2004; 99: 292-298 (Pubitemid 38279872)
13. Bhardwaj B, Qian K, Detmer J et al. Detection of GB virus-C/hepatitis G virus RNA in serum by reverse transcription polymerase chain reaction. J Med Virol 1997; 52: 92-96 (Pubitemid 27243560)
14. Heringlake S, Osterkamp S, Trautwein C et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-1629 (Pubitemid 27007063)
15. Michitaka K, Durazzo M, Tillmann HL et al. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology 1994; 106: 1603-1610 (Pubitemid 24163133)
16. Umemura T, Tanaka E, Ostapowicz G et al. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis 2003; 188: 1545-1552 (Pubitemid 37523941)
17. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 1993; 105: 1522-1528
18. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699
19. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938 (Pubitemid 29514229)
20. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993; 259: 946-951 (Pubitemid 23080660)
21. Hubank M, Schatz DG. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 1994; 22: 5640-5648
22. Pastorian K, Hawel 3rd L, Byus CV. Optimization of cDNA representational difference analysis for the identification of differentially expressed mRNAs. Anal Biochem 2000; 283: 89-98
23. Geller SA, Nichols WS, Rojter SE et al. Hepatitis C virus is not recoverable from liver tissue in cryptogenic cirrhosis: failure to identify hepatitis C virus-RNA using reverse transcription-mediated polymerase chain reaction. Hum Pathol 1996; 27: 1161-1165 (Pubitemid 26374935)
24. Gelderblom HC, Menting S, Beld MG. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum. Antivir Ther 2006; 11: 95-103 (Pubitemid 43306082)
25. Laperche S, Thibault V, Bouchardeau F et al. Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study. J Clin Microbiol 2006; 44: 3600-3607 (Pubitemid 46768819)
26. Pardo M, Lopez-Alcorocho JM, Rodriguez-Inigo E et al. Comparative study between occult hepatitis C virus infection and chronic hepatitis C. J Viral Hepat 2007; 14: 36-40 (Pubitemid 46012359)
27. Alter HJ, Nakatsuji Y, Melpolder J et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-754 (Pubitemid 27113968)
28. Alter MJ, Gallagher M, Morris TT et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med 1997; 336: 741-746
29. Heringlake S, Tillmann HL, Cordes-Temme P et al. GBV-C/HGV is not the major cause of autoimmune hepatitis. J Hepatol 1996; 25: 980-984 (Pubitemid 27008134)
30. Laskus T, Wang LF, Radkowski M et al. Hepatitis G virus infection in American patients with cryptogenic cirrhosis: no evidence for liver replication. J Infect Dis 1997; 176: 1491-1495
31. Pessoa MG, Terrault NA, Ferrell LD et al. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology 1997; 25: 1266-1270 (Pubitemid 27199960)
32. Tagger A, Ribero ML, Larghi A et al. Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease. Am J Gastroenterol 1999; 94: 484-488 (Pubitemid 29084674)
33. Chang Y, Cesarman E, Pessin MS et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869
34. Simons JN, Pilot-Matias TJ, Leary TP et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-3405
35. Simons JN, Leary TP, Dawson GJ et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1: 564-569
36. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-1219 (Pubitemid 36538699)
37. Abdelmalek M, Ludwig J, Lindor KD. Two cases from the spectrum of nonalcoholic steatohepatitis. J Clin Gastroenterol 1995; 20: 127-130
38. Caldwell SH, Oelsner DH, Iezzoni JC et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669 (Pubitemid 29109578)
39. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000; 32: 689-692
40. Struben VM, Hespenheide EE, Caldwell SH. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 2000; 108: 9-13 (Pubitemid 30058272)
41. Rector RS, Thyfault JP, Wei Y et al. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 2008; 14: 185-192
42. Tellez-Avitla FI, Sanchez-Avila F, Garcia-Saenz-de-Sicilia M et al. Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis. World J Gastroenterol 2008; 14: 4771-4775
43. Ballot E, Homberg JC, Johanet C. Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis. J Hepatol 2000; 33: 208-215 (Pubitemid 30485224)
44. Manns MP, Kruger M. Immunogenetics of chronic liver diseases. Gastroenterology 1994; 106: 1676-1697 (Pubitemid 24163143)
45. Potthoff A, Deterding K, Trautwein C et al. Steroid treatment for severe acute cryptogenic hepatitis. Z Gastroenterol 2007; 45: 15-19 (Pubitemid 46202716)
46. Csepregi A, Rocken C, Treiber G et al. Budesonide induces complete remission in autoimmune hepatitis. World J Gastroenterol 2006; 12: 1362-1366
47. Wiegand J, Schueler A, Kanzler S et al. Budesonide in previously untreated autoimmune hepatitis. Liver Int 2005; 25: 927-934 (Pubitemid 41404011)